ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2016 American Transplant Congress

    Pre-Mortem Cannulation and NECMO Preservation for DCD Liver Transplantation.

    P. Ruiz,1 M. Gastaca,1 A. Valdivieso,1 A. Ventoso,1 I. Palomares,1 M. Prieto,1 J. Bustamante,2 P. Salvador,2 J. Ortiz de Urbina.1

    1Liver Surgery and Liver Transplant Unit, Cruces University Hospital, Bilbao, Vizcaya, Spain; 2Hepatology and Liver Transplant Unit, Cruces University Hospital, Bilbao, Vizcaya, Spain.

    Introduction: Herein, we present the short-term results of a controlled DCD liver transplantation program with pre-mortem cannulation and normothermic extracorporeal membrane oxygenation (NECMO) preservation.Material and…
  • 2016 American Transplant Congress

    Protective Effects of Nrf2 Over-Activation in Myeloid Cells During Hepatic Ischemia Reperfusion Correlates with Stat3 Signaling in Hepatocytes.

    C. Harberg,1 L.-Y. Lee,1 S. Werner,2 D. Johnson,3 J. Johnson,3 D. Foley.1

    1Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI; 2Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology, Zurich, Switzerland; 3Pharmaceutical Sciences, University of Wisconsin School of Pharmacy, Madison, WI.

    Ischemia-reperfusion injury (IRI) is a consequence of liver resection and liver transplantation. The Nrf2-antioxidant response element pathway is a key mediator of cellular defense against…
  • 2016 American Transplant Congress

    The Use of Perioperative Lactate Values as Markers for Adverse Outcomes in Liver Transplantation.

    B. Rao,1 A. Yoshida,3 M. Ibrahim,2 S.-M. Jafri.2

    1Internal Medicine, Henry Ford Hospital, Detroit, MI; 2Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI; 3Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI.

    Introduction:We examined the utility of perioperative lactate values for the prediction of multiple post-transplant outcomes including length of hospital stay (LOS), acute cellular rejection (ACR),…
  • 2016 American Transplant Congress

    Innate Immune Signaling During Ischemia-Reperfusion Injury in Human Orthotopic Liver Transplantation.

    R. Sosa,1 A. Zarrinpar,2 C. Lassman,1 R. Busuttil,2 D. Gjertson,1 J. Kupiec-Weglinski,1 E. Reed.1

    1Pathology and Lab Medicine, University of California-Los Angeles, Los Angeles, CA; 2Surgery, University of California-Los Angeles, Los Angeles, CA.

    Background: Orthotopic liver transplantation (OLT) success is hampered by cellular damage elicited by ischemia-reperfusion injury (IRI) which lowers allograft survival. Research using murine models has…
  • 2016 American Transplant Congress

    Effect of Conversion to mTOR Inhibition on Allograft Fibrosis in Pediatric Liver Transplantation.

    R. Fischer,1 S. Foster,2 A. Kats,1 W. Andrews,1 R. Hendrickson,1 J. Daniel.1

    1Children's Mercy Hospital, Kansas City, MO; 2University of Kansas Medical Center, Kansas City, KS.

    Background: Serial surveillance biopsies demonstrate post-transplant inflammation and fibrosis in long-surviving liver allografts. These findings can lead to cirrhosis and graft failure. We compared two…
  • 2016 American Transplant Congress

    Hepatitis C Eradication with Sofosbuvir Based Regimens Leads to Significant Metabolic Changes in Post Orthotopic Liver Transplant Patients.

    A. Morales,1 M. Singla,2 H. Greenwald,1 S. Robertazzi,1 C. Rodigas,1 V. Washington,1 R. Satoskar,1 C. Smith.1

    1MedStar Transplant Institute, Georgetown University Hospital, Washington, DC; 2Gastroenterology Service, Walter Reed National Military Medical Center, Bethesda, MD.

    The purpose of this study was to assess the effect of hepatitis C virus (HCV) eradication with sofosbuvir based regimens on glycemic and lipid control…
  • 2016 American Transplant Congress

    Living Donor Liver Transplant Has Similar Outcome to Deceased Donor Liver Transplant for MELD > 25.

    M. Al Sebayel,1 F. Abaalkhail,1,2 M. Shoukri,1 H. Albahili,1,2 S. Alabbad,1 W. AlHamoudi,1,2,3 H. Albeshbeshy,1 H. Elsiesy.1,2

    1Liver Transplantation, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; 2Alfaisal University, Riyadh, Saudi Arabia; 3Department of Gastroenterology, King Saud University, Riyadh, Saudi Arabia.

    Background and Aims: Model for End-Stage Liver Disease (MELD) score is universally used to prioritize patients on the liver transplant (LT) waiting list. There has…
  • 2016 American Transplant Congress

    Primary Outcome of iWITH: A Multi-Center Clinical Trial of Complete Immunosuppression Withdrawal (ISW) in Stable Pediatric Liver Transplant (LT) Recipients.

    S. Feng,1 J. Bucuvalas,2 A. Demetris,3 K. Spain,4 S. Kanaparthi,5 J. Magee,6 G. Mazariegos,3 The iWITH Investigators.7

    1UCSF, San Francisco; 2CCHMC, Cincinnati; 3U Pitt, Pittsburgh; 4Rho, Chapel Hill; 5ITN, Bethesda; 6U Mich, Ann Arbor; 7NIAID/NIDDK/ITN, Bethesda.

    AIM: Test the hypothesis that a selected cohort of pediatric LT recipients can safely undergo complete ISW followed by assessment for operational tolerance (OT)METHODS: 88…
  • 2016 American Transplant Congress

    Glycine Is Graft Protective and Improves Kidney Function After Liver Transplantation: Data from HEGPOL-Trial.

    A. Nickkholgh,1 P. Schemmer,1 G. Polychronidis,1 S. Luntz,2 E. Mayatepek,3 M. Büchler,1 E. Klar.4

    1General, Abdominal and Transplant Surgery, Ruprecht-Karls University, Heidelberg, BW, Germany; 2Coordination Center for Clinical Trials (KKS), Heidelberg, BW, Germany; 3Department of General Pediatrics, Heinrich-Heine-University, Düsseldorf, RP, Germany; 4Department of Surgery, University of Rostock, Rostock, Germany.

    Introduction: In experimental liver transplantation (LTx), glycine, a non-essential amino acid, has been shown to prevent the activation of Kupffer cells and to reduce ischemia/reperfusion…
  • 2015 American Transplant Congress

    Tobacco Use Is a Significant Risk Factor for Post-Transplant Biliary Complications

    D. Dulaney, M. Dokus, M. Orloff, R. Kashyap.

    Surgery, University of Rochester Medical Center, Rochester, NY.

    Purpose: Biliary complications following liver transplantation are a significant source of morbidity, potentially leading to graft failure necessitating retransplantation. Smoking precipitates both microvascular and macrovascular…
  • « Previous Page
  • 1
  • …
  • 160
  • 161
  • 162
  • 163
  • 164
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences